Editorial overview: Gastrointestinal: New frontiers in therapeutics for GI diseases and disorders — from microRNAs to novel pharmaceutics, to low FODMAP diets and microbiome

TY - JOUR

T1 - Editorial overview

T2 - Gastrointestinal: New frontiers in therapeutics for GI diseases and disorders — from microRNAs to novel pharmaceutics, to low FODMAP diets and microbiome

AU - Christofi, Fievos L.

AU - Bharucha, Adil E.

N1 - Funding Information: Fievos L Christofi is a Professor and Vice Chair of Research in the department of Anesthesiology, and member of the Neurological Institute, The Ohio State University, Columbus, Ohio, USA. He is a councilor of the American Neurogastroenterology & Motility Society (ANMS) and Chair of ANMS grants review committee. His research interests are in enteric neurobiology and motility — his focus is to better understand the role of gut purines in health and disease and explore the potential of ‘purinergic drugs’ for GI diseases and disorders such as IBD, IBS and postoperative ileus. He received a Janssen research Award in Gastroenterology. His research is funded by NIH, Diabetes, Digestive & Kidney Diseases (DK113943) & OSU Dean's Funds. He serves as a research mentor to students, postdocs and 2 NIH LRP grant trainees.

PY - 2017/12

Y1 - 2017/12

UR - http://www.scopus.com/inward/record.url?scp=85037616673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037616673&partnerID=8YFLogxK

U2 - 10.1016/j.coph.2017.11.011

DO - 10.1016/j.coph.2017.11.011

M3 - Editorial

C2 - 29224799

AN - SCOPUS:85037616673

SN - 1471-4892

VL - 37

SP - iv-viii

JO - Current Opinion in Pharmacology

JF - Current Opinion in Pharmacology

ER -